FDA Approves First New Therapy to Treat Heart Attacks in Years
Heart assaults are generally handled through putting stents on the websites of narrowing coronary arteries. This has change into an ordinary of care and advances in cath lab applied sciences lets in interventional cardiologists to as it should be position stents in an issue of mins.
Now another choice, referred to as SuperSaturated Oxygen (SSO2), is being made to be had thank you to a brand spanking new approval from the FDA. SSO2 is the primary remedy authorized through the FDA since percutaneous coronary intervention (PCI, aka stenting) to lend a hand cut back the wear and tear that center assaults motive.
The treatment, advanced through TherOx, an organization based totally in Irvine, California, comes to pumping hyperbaric ranges of oxygen immediately to oxygen-deprived myocardium simply after PCI is entire and blood drift is restored. Specifically, it’s indicated for sufferers affected by left anterior descending ST-elevation myocardial infarction (LAD STEMI) and inside six hours of signs onset.
“Even after angioplasty with stenting, many heart attack patients suffer from irreversible damage to the heart muscle, which carries a poor prognosis in terms of mortality and the potential for future heart failure,” mentioned Gregg W. Stone, M.D., professor of medication, Columbia University Medical Center, in a TherOx announcement. “SuperSaturated Oxygen is the only therapy shown in a pivotal randomized trial to reduce infarct size in patients with large anterior myocardial infarction, offering the potential to further improve outcomes in these high-risk patients despite successful primary angioplasty.”
Product web page: TherOx DownStream System…
(serve as(d, s, identification) (record, ‘script’, ‘facebook-jssdk’));